InfuSystem Holdings (INFU) Change in Receivables (2010 - 2026)
InfuSystem Holdings (INFU) reported Change in Receivables of $2.2 million for Q1 2026, up 7.4% on a YoY basis from $2.1 million in Q1 2025, and up 192.59% quarter-over-quarter from -$2.4 million in Q4 2025.
InfuSystem Holdings (INFU) Change in Receivables (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Change in Receivables for 11 years, with the latest figure at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 7.4% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at -$108000.0 (down 104.22% YoY), and the FY2025 full-year result was -$263000.0, down 137.52% from the prior year.
- Change in Receivables for Q1 2026 stood at $2.2 million, up from -$2.4 million in the prior quarter.
- The five-year high for Change in Receivables was $2.2 million in Q1 2026, with the low at -$2.4 million in Q4 2025.
- Historically, Change in Receivables has averaged $364941.2 across 5 years, with a median of $237000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Receivables plunged 289.01% — and 2025, when it soared 783.97%.
- InfuSystem Holdings' Change in Receivables stood at $546000.0 in 2022, then jumped by 143.22% to $1.3 million in 2023, then slumped by 148.72% to -$647000.0 in 2024, then sank by 275.58% to -$2.4 million in 2025, then jumped by 192.59% to $2.2 million in 2026.
- The last three Change in Receivables figures came in at $2.2 million (Q1 2026), -$2.4 million (Q4 2025), and $78000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.50 Mn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 2.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Sep 30, 2025 | 78,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | -647,000.00 |
| Dec 31, 2024 | -647,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 966,000.00 |
| Jun 30, 2024 | 966,000.00 |
| Mar 31, 2024 | 237,000.00 |
| Mar 31, 2024 | 237,000.00 |
| Dec 31, 2023 | 1.33 Mn |
| Dec 31, 2023 | 1.33 Mn |